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Abstract 18 
The B cell repertoire is generated in the adult bone marrow by an ordered series of gene rearrangement 19 
processes that result in massive diversity of immunoglobulin (Ig) genes, and consequently an equally 20 
large number of potential specificities for antigen.  As the process is essentially random, then cells 21 
exhibiting excess reactivity with self-antigens are generated and need to be removed from the repertoire 22 
before the cells are fully mature.  Some of the cells are deleted, and some will undergo receptor editing 23 
to see if changing the light chain can rescue an autoreactive antibody.  As a consequence, the binding 24 
properties of the B cell receptor are changed as development progresses through pre-25 
B>>immature>>transitional>>naïve phenotypes.  Using long-read, high-throughput, sequencing we 26 
have produced a unique set of sequences from these four cell types in human bone marrow and matched 27 
peripheral blood and our results describe the effects of tolerance selection on the B cell repertoire at the 28 
Ig gene level.  Most strong effects of selection are seen within the heavy chain repertoire, and can be 29 
seen both in gene usage and in CDR-H3 characteristics.  Age-related changes are small and only the 30 
size of the CDR-H3 shows constant and significant change in these data.  The paucity of significant 31 
changes in either kappa or lambda light chain repertoires implies that either the heavy chain has more 32 
influence over autoreactivity than light chain and/or that switching between kappa and lambda light 33 
chains, as opposed to switching within the light chain loci, may effect a more successful autoreactive 34 
rescue by receptor editing.  Our results show that the transitional cell population contains cells other 35 
than those that are part of the pre-B>>immature>>transitional>>naïve development pathway, since the 36 
population often shows a repertoire that is outside the trajectory of gene loss/gain between pre-B and 37 
naïve stages.    38 
Introduction 39 
B cells development starts in the bone marrow, from a hematopoietic stem cell precursor, and 40 
undergoes an ordered series of differentiation steps to ultimately generate mature naïve B cells in the 41 
peripheral blood (1). As development progresses the B cell receptor (BCR) is generated and adjusted 42 
to ensure that cells are not overly autoreactive.  First, at the initial pro-B cell stage heavy chain gene 43 
recombination occurs, such that the random selection and joining of IGHV, IGHD and IHGJ genes 44 
produces a complete heavy chain.  As cells develop into pre-B cells the heavy chain is then presented 45 
on the surface of the cell, in conjunction with a surrogate light chain, so that selection of productive 46 
heavy chains can take place. Cells without a productive heavy chain gene rearrangement are removed 47 
from the repertoire, whilst cells containing productive heavy chains undergo a few rounds of 48 
proliferation and are designated ‘large’ pre-B cells (2). After this point light chain recombination of 49 
IGK or IGL genes occurs within each cell in order to produce cells with rearranged heavy (IgM) and 50 
light chain genes (3-5). Expression of the complete antibody on the surface on these immature B cells 51 
enables the first tolerance checkpoint such that some cells carrying receptors with too high an affinity 52 
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for self-antigens undergo receptor editing to change the light chains (6).  Lack of a functional 53 
surrogate light chain somehow interferes with this tolerance checkpoint (7).  It has been shown that 54 
55.2% (n= 29) of  early immature B cells carried polyreactive immunoglobulin genes, and this was 55 
reduced by receptor editing, or deletion from the repertoire, so that only 7.4% (n= 72) of transitional 56 
cells exiting the bone marrow carried polyreactive antibodies (8).  The term “Transitional cells” was 57 
originally coined to categorise the group of early emigrant cells from the bone marrow.  These cells 58 
express IgD and CD10 alongside the IgM BCR so can be identified as IgD+ CD27–CD10hi/+ (9). Co-59 
expression of high levels of CD24 and CD38 have also frequently been used to identify them, and it is 60 
important that CD27 be included if this is the case since the CD38hiCD24hi population can contain 61 
CD27+ cells that may be more akin to the IgM memory populations (10).  Heterogeneity has been 62 
seen within transitional cells such that T1 (CD38+++CD24hiCD10++IgDlo/–), T2 63 
(CD38++CD24hiCD10+IgD+) and T3 (CD38+CD24+IgD+ABCB1–) subpopulations have been identified 64 
(9, 11, 12). T1 cells have been shown to be highly prone to spontaneous apoptosis and are hard to 65 
rescue even with BCR or T cell stimulation (13, 14), thereby providing another opportunity for 66 
negative selection during tolerance and removal of autoimmunity (8, 15). T2 cells were thought to be 67 
less responsive to negative selection and more responsive to antigen stimulation allowing for positive 68 
selection to occur (13, 14, 16, 17) . The functional classification of CD38hiCD24hicells as transitional 69 
cell intermediates between bone marrow and peripheral naïve B cells in development has also been 70 
complicated by the discovery of human regulatory B cells (Bregs), which are also CD38hiCD24hi (18) 71 
In humans, the gradual loss of CD10, CD5 and IgM and the upregulation of CD22, CD44, CD21 and 72 
CD23 as cells progress from immature to transitional (TI to T2 to T3) to mature naïve cells, along with 73 
the generation of naïve cells from stimulated transitional cells (9, 19), lead to the current paradigm: 74 
That B cells develop from pre-B cells through immature cells in the bone marrow to transitional cells 75 
in the periphery and then to peripheral naïve cells in a linear pathway (20).   76 
Positive and negative selection events that occur in B cell development are expected to shape the 77 
repertoire of B cell populations in terms of in terms of V, D, J gene usage and CDRH3 properties. We 78 
have previously shown that different stages of memory B cell development have distinct repertoire 79 
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characteristics (21-23). Notably an increase in IGHV3 family at the expense of IGHV1 family in IgM 80 
memory cells, but not switched memory cells (21) has been seen, and a decrease in the overall CDR3 81 
length which is partially (but not wholly) caused by an increase of IGHJ4 family usage at the expense 82 
of IGHJ6 family usage is observed in  memory cells in general (21-25).   The selection events that 83 
occur during central and peripheral tolerance will shape the immunoglobulin repertoire due to the 84 
removal of unwanted autoreactive cells. Comparison between passenger out-of-frame 85 
immunoglobulin genes and in-frame immunoglobulin genes in human naïve cells indicates that B cell 86 
selection has already occurred before exogenous antigen activation (26). Cloning of up to 131 Ig 87 
genes from pre-B, immature and mature B cell subsets indicates there may be differences in CDRH3 88 
characteristics due to negative selection processes (27). However, little information is available on the 89 
expressed immunoglobulin repertoire as a whole in the early stages of development in the human 90 
bone marrow. Here we have used high throughput sequencing to define the heavy and light chain B 91 
cell repertoire in pre-B and immature cells from human bone marrow, alongside donor-matched 92 
transitional and naïve B cells from the peripheral blood, to provide an overall picture of the 93 
consequences of early selection events on human B cell repertoire.  94 
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Methods 96 
Sample collection 97 
Bone marrow and peripheral blood was obtained from 19 healthy adult donors (aged 24-86) with no 98 
known disease affecting the immune system and undergoing total hip replacement surgery at Guy’s 99 
Hospital, London, UK. The samples were collected with informed consent under the REC number 100 
11/LO/1266. 101 
 102 
B cell isolation and sorting 103 
The B cells were isolated and sorted as previously published (28). Briefly, bone marrow (BM) 104 
material was removed from the head of the femur and filtered into RPMI-1640 (Sigma Aldrich).  BM 105 
mononuclear cells (BMMCs) and peripheral blood mononuclear cells (PBMCs) were isolated using 106 
Ficoll-Paque PLUS (GE Healthcare Life Sciences) according to the manufacturer’s instructions.  For 107 
the BMMCs, CD19+ B cells were then enriched to >98% using CD19 microbead magnetic separation 108 
(Miltenyi).  109 
BMMCs were stained using PE anti-human Ig light chain lambda (MHL-38, BioLegend), APC anti-110 
human Ig light chain kappa (MHK-49, BioLegend), PE/Cy7 anti-human CD38 (HIT2, 111 
BioLegend), PerCP/Cy5.5 anti-human IgD (IA6-2, BioLegend), Pacific Blue anti-human IgM 112 
(MHM-88, BioLegend), APC/Cy7 anti-human CD10 (HI10a, BioLegend) and FITC CD27 (M-113 
T271, Miltenyi Biotec). PBMCs were stained using CD19 APC (HIB19, BD BioScience), IgD 114 
PerCP/Cy5.5 (IA6-2, BioLegend), CD27 FITC (M-T271, Miltenyi Biotec) and CD10 APC/Cy7 115 
(HI10a, BioLegend).  116 
B cells were sorted into Sort Lysis Reverse Transcription (SLyRT)(21) buffer using the FACS Aria 117 
(BD BioSciences). B cells were sorted into four cell types: large pre-B (IgK-IgL-CD38+IgM+), 118 
immature (IgK+ or IgL+CD27–IgM+IgD–CD10+), transitional (IgD+CD27–CD10+) and naïve 119 
(IgD+CD27–CD10-) as shown in Figure 1. Due to the lytic (RNA stabilising) nature of the sort buffer 120 
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and the rarity of some of the cell populations we were unable to check post-sorting purity.  We set the 121 
collection gates well away from the FMO control gates as a precautionary measure (Figure 1b,c). 122 
 123 
High throughput sequencing and data clean up 124 
High throughput sequencing was carried out as previously described (21, 29). Briefly, reverse 125 
transcription was performed directly on the sample immediately after sorting and then a semi-nested 126 
PCR was performed, adding multiplex identifiers (MIDs) to distinguish patients (29). High 127 
throughput sequencing was carried out using the Roche 454 GS FLX system (LGC Genomics) and 128 
data clean-up was performed as before Wu, Kipling (29). In addition, for analysis of the CDR3 129 
peptide sequence character, the data was cleaned to remove sequences where the CDR3 was likely 130 
inaccurate as a result of sequencing error, i.e. CDR3 regions outside the normal distribution of CDR3 131 
lengths (1 to 35 amino acids for heavy chain and 1 to 20 amino acids for light chain) and/or sequences 132 
identified by IMGT as unproductive.    133 
V(D)J gene assignment was carried out using IMGT/HighV-QUEST (30, 31). The physicochemical 134 
properties of the CDR3 amino acid sequences were calculated using the R package Peptides (32, 33) 135 
and clustering analysis of the Ig gene sequences was carried out using levenstein distance on the 136 
CDR3 regions using R scripts available on our website (34). 137 
As all of the repertoires were antigen-naïve, then true clonal expansions would be negligible.  138 
Therefore, in order to remove biases caused by PCR amplification, only unique gene rearrangements 139 
were used for this analysis.  Where the clustering identified more than one related sequence a modal 140 
sequence was used to represent the gene rearrangement. The data was stored in CSV files and data 141 
analysis was performed using Microsoft Excel, GraphPad Prism and R. 142 
 143 
Analysis and Statistics 144 
Frequency of gene usage in the repertoire 145 
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The frequency of each gene (both at the individual gene and at the gene family level) observed in the 146 
data was calculated for each cell subset from each donor.  The frequency (in percentage) of each VDJ 147 
family combination (heavy chain), or VJ family combination (light chain) was also calculated for each 148 
cell subset from each donor.  The mean values of gene combination frequencies were calculated for 149 
each cell subset and 3D bubble plots were created using the R package plot3D (35).  Statistical 150 
analysis (Mann-Whitney Wilcoxon test and ANOVA, with post-test analysis where appropriate) was 151 
performed using R or GraphPad Prism. 152 
Physicochemical properties of CDR3 regions 153 
The physicochemical properties of CDR3 regions at heavy and light chains were compared between 154 
different cell types. These properties consisted of length, hydrophobicity indicated by GRAVY index 155 
(36), Boman index (37), molecular weight (Mr), Isoelectric point (pI) (38), aliphatic index (39), 156 
frequency of amino acid classes in the CDR3 region, and Kidera factors (40). The R package lem4 157 
(41) was used for fitting and analysing the mixed model of our data, describing the fixed-effect (cell 158 
types) and the random-effect (patients) in a linear predictor expression. The Likelihood Ratio Test 159 
was calculated with the statistical method ANOVA to estimate the statistical significance between 160 
populations, i.e. a pair of cell subsets.  161 
Clustering and Principal Component Analysis 162 
 163 
Principal Component Analysis (PCA) and clustering, using Minkowski distance, were applied to the 164 
kidera factors and gene usage frequencies from the CDR3 data as follows. Firstly, the mean values of 165 
the kidera factors and gene usage frequencies were computed for each donor. Secondly, the mean 166 
values and frequencies of all donors were grouped and then analysed by PCA and clustering.    167 
PCA was performed using the prcomp function in R. The Minkowski distances (with power of 4) 168 
were calculated using dist(method="minkowski") function in R based on all CDR3 properties. The 169 
distances were then plotted with dendrograms (trees) using the dendrapply function in R. 170 
Randomised datasets were generated by randomly shuffling the sequences across four cell sub-171 
populations. PCA analysis was then performed to be compared with the original dataset in order to 172 
show that our observations of differences between cell sub-populations were not random events. 173 
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 174 
Mass Cytometry 175 
PBMCs were stained with FITC anti-human CD14 and APC anti-human CD3 (clone M5E2 and 176 
UCHT1 respectively), and a population of enriched B cells (CD3–CD14–) was collected into 50% FCS 177 
(Biosera) and 50% RPMI-1640 (Gibco). The CD3–CD14– enriched B cells were labelled with a 178 
rhodium intercalator (Rh103, DVS Sciences) followed by intracellular and extracellular staining with 179 
a panel of 30 different metal-tagged antibodies (DVS Sciences, BD BioSciences and BioLegend). 180 
Cells were fixed, iridium stained (Ir193, DVS Sciences), and normalization beads (DVS Sciences) 181 
were added before analysis on the mass cytometry system (DVS Sciences). Between 1 and 5×105 182 
stained cells were analysed per sample. 183 
Data were normalized and files were concatenated and cleaned up to remove debris (by gating on cell 184 
length and DNA+ cells), to exclude normalization beads (Ce140– cells), to positively select intact cells 185 
(Ir191+Ir193+), to positively select live cells (Rh103–Ir193+), and to identify CD19+ and/or CD20+ B 186 
cells. CD38hiCD24hi B cells were identified and exported as a new group prior to performing 187 
SPADE (Spanning-tree Progression Analysis of Density-normalised Event) analysis (42). SPADE 188 
analysis groups cells into ‘nodes’ based on the expression of all 30 markers to produce a two 189 
dimensional tree. Using a colour coded expression scale, the nodes in the tree were manually grouped 190 
into larger ‘bubbles’ to collect together nodes, and therefore cells, that had similar expression, i.e. all 191 
those with high IgM expression were grouped together in one bubble.  192 
Results 193 
Heavy chain gene family usage distinguishes cell types 194 
Pre-B (large pre-B) and immature B cells, from BM samples, and matched transitional and naïve B 195 
cells, from PB samples, were sorted (Figure 1b and c) prior to high throughput sequencing using an 196 
IgM specific constant region primer. Both the heavy and light chain (kappa and lambda) Ig genes 197 
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were amplified with a total of 96,593 heavy and 49,101 light chain sequences generated after initial 198 
data clean up. These B cell populations are all thought to be exogenous antigen-naïve and therefore 199 
will not have been activated to undergo somatic hypermutation and expansion.  We do not see 200 
evidence of somatic hypermutation in the gene sequences (data not shown) and therefore we have 201 
assumed that any sequences with the same CDR3 region arise from PCR duplication.  Therefore only 202 
one example sequence of any unique gene rearrangement was used in this analysis, resulting in 39,577 203 
heavy chain and 42,542 light chain sequences grouped by donor and cell type. Sequencing error does 204 
not substantially affect the assignment of germline Ig genes to the sequences, however, for the CDR3 205 
peptide analysis we further removed sequences where the peptide sequence may be inaccurate due to 206 
sequencing error.  This resulted  in 29,074 heavy chain and 29,128 light chain sequences. Sequences 207 
can be accessed on the National Center for Biotechnology Information's Sequence Read Archive in 208 
raw format (BioProject: PRJNA39946; Sequence Read Archive accession: SRP081849) or in 209 
processed format with metadata at www.bcell.org.uk. 210 
Gene family repertoire can distinguish early human B cell subsets 211 
Heavy chain V, D and J family usage did not show any significant differences in repertoire between 212 
pre-B and immature cells from the bone marrow.   There were, however, significant differences 213 
between these BM cells and the peripheral transitional and naïve cells (Figure 2).  IGHV3 family 214 
genes are the most predominant genes in the human peripheral repertoire.  It was interesting that in 215 
the bone marrow this was particularly the case, with IGHV3 cells actually being removed from the 216 
repertoire during B cell maturation: There is a highly significant >13% decrease in the use of IGHV3 217 
family genes in naïve cells with small increases in all other families to compensate (Figure 2a).  Naïve 218 
cells also showed a significantly decreased use of IGHJ6 and, together with transitional cells, a >6% 219 
reduction in use of IGHD2 family genes. 220 
Since we had expected that peripheral transitional cells would fall between immature bone marrow 221 
cells and peripheral naïve cells in the development pathway, and that any changes in repertoire we 222 
saw would reflect this, we were surprised to see that this was not always the case.  There was a 223 
significant 5% increased frequency of IGHD3 family usage in transitional cells compared to all other 224 
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cell types. Furthermore, there was a significant >9% increase in IGHJ6 usage, compensated for by 225 
decreases in IGHJ3,4 and 5 usage, in transitional cells compared to all other cell types.  This is 226 
reflected in the different size of bubble V3D3J6 in the bubble plots (Figure 2B).  The different 227 
repertoire of transitional and naïve cells compared to the bone marrow cells (p<0.05, Wilcoxon), and 228 
compared to each other (p<0.001, Wilcoxon) is illustrated by a PCA analysis of gene family usage 229 
(Figure 2c).   230 
Light chain repertoire is less variable.  231 
In contrast to the heavy chain repertoire, the light chain gene family repertoire does not distinguish 232 
between cell types. There are no significant changes in kappa family usage (Figure 3a).  Some 233 
differences were seen in lambda families (Figure 3b). The IGLV2 family usage is significantly 234 
increased by 10-15%, at the expense of all other families, and IGLJ1 family usage is significantly 235 
increased by 2-5%, at the expense of IGLJ3.  As a result of this an ANOVA analysis of the 236 
combinatorial lambda family repertoire showed a significant difference between the immature and the 237 
transitional and naïve stages of development (p<0.001).  However, clustering by PCA showed that 238 
any differences in light chain V-J gene usage were not strong enough to be able to distinguish 239 
between the different cell types (Figure 3e).  Nor were there any obvious differences between the 240 
different cell types in lambda CDR3 amino acid sequence, since PCA of the kidera factors to assess 241 
the physicochemical character of the CDR3 did not distinguish between the groups (Figure 3f). 242 
Selection of individual IGH genes in early development 243 
As the above analysis of gene family repertoire indicated that there were repertoire changes between 244 
cell types, we analysed all the genes individually to check if we had missed any significant gene 245 
selection due to the averaging effect of looking at the family level (Figure 4).  Not all the IGHV3 246 
family genes are decreased in naïve cells compared to bone marrow cells.  While there are significant 247 
decreases in IGHV3-15, IGHV3-30 and IGHV3-33 in particular, IGHV3-9 is actually increased 248 
(Figure 4a). Other notable increases occur in the two main IGHV1 family genes: IGHV1-18 and 249 
IGHV1-69, and in the IGHV6 gene.  The IGHD2 family decreases are contributed by IGHD2-15 and 250 
IGHD2-2, and while the compensatory increase in other IGHD genes seemed unremarkable across the 251 
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board, IGHD1-7 and IGHD4-17 did show significant differences (Figure 4b). In spite of the 252 
significant change in IGHD3 family use in transitional cells, this did not show up at the individual 253 
gene level, implying that the increase occurs throughout the IGHD gene family.  Despite the lack of 254 
significant changes in IGK family repertoire there was a small (~3.8%) but significant increase in 255 
IGKV3-11 gene use in naïve cells compared to immature cells.  This appeared to be at the expense of 256 
small (<3%) decreases in IGKV3-20 and IGKV4-1 genes. The increase in IGLV2 family during 257 
development seemed to be mainly due to significant increases of 12.8% and 7% in IGL2-14 and 258 
IGL2-23 respectively (Figure 4c).   259 
There is a certain amount of inter-individual variation that occurs in these analyses but the trends for 260 
selection of these genes in the repertoire are consistent, as illustrated in Figure 4, where the individual 261 
donors are shown separately for genes that are removed from the repertoire (Figure 4d) or that are 262 
increased in the repertoire (Figure 4e) during early development. 263 
Heavy chain CDR3 properties are also strongly selected. 264 
Although much of the CDR3 region is comprised of contributions from the individual IGHV, IGHD 265 
and IGHJ genes, reflecting some of the repertoire selection effects that are captured in the analysis 266 
above, the actual amino acid sequences encoded by CDR3 varies tremendously even within the same 267 
VDJ combinations.  In addition to the direct effects of endonuclease action on the genes, and N region 268 
insertion by terminal deoxynucleotidyl transferase, the reading frame of the IGHD region can also 269 
vary. Since the CDR3 region encodes a crucial part of the antibody binding site, and key functional 270 
aspects of its structure are dependent on the primary sequence (43), we also analysed the biophysical 271 
characteristics of the CDR3 amino acid sequence.  Initially we used Kidera factors, which are a set of 272 
10 orthogonal factors that encapsulate information from ~140 different measurable biophysical 273 
characteristics of peptides.  The data from PCA analysis of the CDR3 Kidera factors is in accordance 274 
with that for the VDJ gene analysis, showing that the characteristics of pre-B and immature cells are 275 
found in overlapping clusters (Figure 5a).  Naïve cells and transitional cells, however, form separate 276 
yet non-overlapping clusters. The data from heavy chain CDR3 Kidera analysis separates the groups 277 
of cells better than the gene usage data, with 30% of the data contributing to PC1. To elucidate which 278 
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characteristics were mainly responsible for the differences we analysed some of the most common 279 
ones individually.  The numbers of charged, basic and aromatic amino acids in each sequence, and the 280 
sequence Boman index, were significantly increased in naïve cells compared to pre-B cells (Figure 281 
5b).  Conversely, the number of small amino acids per sequence, the hydrophobicity (GRAVY index), 282 
aliphatic index and overall length of sequence were all disfavoured characteristics that were removed 283 
from the repertoire during development (Figure 5c).  Interestingly the selection on the size of CDR3 284 
region did not seem as strong in the older donors as it did in the younger ones (Figure 5d). 285 
Human transitional cells are not just precursors to naïve cells.   286 
The heavy chain gene and CDR3 PCA analysis (Figure 2c and Figure 5a) indicated that transitional 287 
cells, in additional to being distinctive from pre-B cells and immature cells, also had a different 288 
repertoire to naïve cells.  We used cluster analysis (based on Minkowski distances) to investigate the 289 
relationships further, which confirmed, by both VDJ usage (Figure 6a) and Kidera factors (Figure 6c), 290 
that transitional cells have a different repertoire to the other cell types.   Naïve cells formed a sub-291 
branch of the cluster containing pre-B and immature cells suggesting that the naïve repertoire is more 292 
similar to the bone marrow cells than to the transitional cells.  Clear examples of individual genes 293 
where the usage in transitional cells differs from the rest of the cells can be seen in Figure 6b, and 294 
biophysical characteristics showing the significantly different character of the heavy chain CDR3 in 295 
transitional cells are shown in Figure 6d. Since this subset of cells has been reported to contain 296 
regulatory B cells, as well as being the precursor to naïve B cells, we investigated the heterogeneity of 297 
the population by mass cytometric analysis of surface markers.  Although the population is small, it 298 
does appear to contain a number of different potential subpopulations, as illustrated by the IgM 299 
SPADE plot in Figure 6e. 300 
Discussion 301 
The lack of difference between the heavy chain repertoire in pre-B and immature B cells implies that 302 
there is very little selective pressure at this developmental stage, which is in agreement with current 303 
thinking on the tolerance checkpoints (44).  As expected, we do see a major difference between 304 
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immature bone marrow B cells and the transitional and naïve mature peripheral B cells, where we 305 
would expect the repertoire to reflect the changes incurred as a result of the post-immature selective 306 
processes that can remove up to 50% of the repertoire (8).  There is a wealth of literature on the heavy 307 
chain gene usage in different conditions, and both negative and positive associations have been made 308 
for various genes.  For example, the common IGHV1 family genes IGHV1-18 and IGHV1-69 have 309 
been associated with responses to viral infections as well as with stereotypical receptors in CLL. It is 310 
interesting that these two genes increase, and a number of IGHV3 family genes decrease, since this 311 
recapitulates the change in repertoire between naïve and switched memory repertoire (21).  Indeed the 312 
relative use of IGHV1 and IGHV3 genes seems to be a marker that distinguished between a number of 313 
different B cell types (25).  Furthermore, the significant changes in CDRH3 are to be expected from a 314 
selected population, since this forms the most important part of the antibody binding site in all except 315 
the smallest CDRH3 regions.  What was particularly striking from this data was that the selection in 316 
CDRH3 appeared to change with age even at this early stage in development, particularly in the 317 
length of the CDRH3 region.  We, and others, have previously noted that shorter CDRH3 regions are 318 
selected upon exogenous antigen selection (21, 28, 45), and that older people have longer CDRH3 319 
regions than in the young when measured in peripheral blood IgM-expressing cells.  This data shows 320 
that a longer CDRH3 exists in B cells even before exogenous antigen stimulation so is likely a result 321 
of changes in bone marrow tolerance selection rather than any exogenous antigen selection of IgM 322 
memory cells. 323 
Receptor editing to rescue potentially autoreactive B cells can occur after the immature B cell stage 324 
once the light chain has been co-expressed.   The light chain loci continue rearrangement to form a 325 
new gene.  The kappa light chain locus rearranges before the lambda locus, and has the potential to 326 
rearrange a number of times.  However, at some point the kappa locus would run out of genes to 327 
rearrange, or the kappa deleting element would be used, in which case then the lambda locus would 328 
start rearrangement (3, 5).  With this in mind, the paucity of differences in light chain repertoire 329 
between immature, transitional and naïve cells is quite surprising.  The kappa repertoire in particular 330 
does not change much, possibly indicating that that the ability of different kappa genes to rescue a 331 
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potentially autoreactive heavy chain gene does not vary much.  Only IGKV3-20 and IGKV4-1 show a 332 
significant decrease in use (Figure 4c), implying a potential contribution to autoreactive BCR.  333 
Indeed, IGKV4-1 has previously been shown to be overrepresented in systemic lupus erythromatosus, 334 
celiac disease and type 1 diabetes (46, 47), and we have also shown that its actual expression in the 335 
peripheral repertoire is significantly lower than its frequency of rearrangement in the genomic DNA 336 
(48).  IGKV3-11 may possibly be a rescue gene, showing a significant increase in use, and our 337 
previous analysis also showed an increase in expression of this gene in the expressed repertoire 338 
compared to its expected frequency of rearrangement (48). Two IGLV2 lambda genes were noted as 339 
being increased within the lambda repertoire, presumably in preference to the IGLV1 family genes 340 
that showed a slight decrease.  Not much is known about the potential significance of lambda light 341 
chain genes, although it has been reported that POEMS syndrome of neuropathy is associated with 342 
monoclonal expansions of IGLV1 family plasma cells (49).  It has been reported that lambda light 343 
chains have a good potential for rescuing autoreactive B cells (50).  Since the primer sets we used for 344 
these experiments amplified the kappa and lambda light chains separately we cannot comment on any 345 
changes in kappa/lambda ration between immature and later B cells.  Given the inability of the light 346 
chain repertoire characteristics to distinguish between the different cell types, as shown by the PCA of 347 
Figure 3e and 3f, it is possible that any light chain-mediated autoreactive rescue would be more likely 348 
to be performed by a switch from kappa to lambda than by a switch within the loci.  Alternatively, the 349 
lack of cell type-distinguishing features in the light chain repertoire could mean that the central 350 
selection events are mainly driven by heavy chain-encoded binding specificities.  The selection in 351 
heavy chain but not light chain also implies that the heavy-light chain pairing is mostly random, since 352 
if the pairing had biases then the same selection effects would appear in both chains.  This is in 353 
agreement with previous data where a large number of paired heavy and light chain rearrangements 354 
were sequenced (51, 52).  It has been previously reported that a particular CDRH3 stereotype on a 355 
IGHV1-69 background might be associated with a particular light chain gene, but this was on a small 356 
sample size (n=66) of selected CLL sequences (53) and the data here represents a much larger 357 
diversity in a normal unselected population of cells.   358 
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What we had not expected to see in these data was the large difference between transitional and naïve 359 
B cells, which does not seem in accord with an immature-transitional-naïve pathway of development.  360 
One assumes that processes in nature have evolved to require minimum energy or resource, and if this 361 
is the case then any change in repertoire between creation (pre-B cells) and end point (naïve B cells) 362 
would be in a single linear direction.  The actual cell-cell differences may vary depending on which 363 
point the selection pressure were applied, but one would not expect to see a change in direction of 364 
increase/decrease one way, followed by a change in direction back again, half way through a 365 
development pathway, i.e. for a gene that was being removed from the repertoire through the 366 
development pathway we would expect the percentage representation in the repertoire to be pre-367 
B>immature>transitional>naïve.  In actual fact, for some genes, we see varying patterns such as 368 
transitional >[pre-B=immature]>naïve.   For this reason, and in the light of results exemplified by use 369 
of IGHV3-53 or use of non-polar CDR3 amino acids (Figure 6b and d), we assume that a large 370 
proportion of the cells in our transitional subset are not intermediates between bone marrow immature 371 
and peripheral naïve B cells.  We sorted our CD19+IgD+CD10hiCD27– cells, based on the previous 372 
information that CD10, CD24, CD38 decrease as cells develop from immature to naïve.  This 373 
information had been obtained by studying the reconstitution of different phenotypic subsets after B 374 
cell depletion (9).  There are three subsets of mature non-memory B cells by the expression of CD10 375 
(high, medium, and low) that have parallels in the differing strengths of CD24hiCD38hi expression in 376 
humans.  These distinctions were first described in mice as T1, T2 and T3 subsets and this 377 
nomenclature has been carried over into human studies (54).  The transitional cell subset in humans 378 
has been shown to contain B cells with regulatory activity after stimulation in vitro (55), and have 379 
also been shown to contain cells with different homing integrins (56).  It is clear from our high 380 
dimensional phenotyping in Figure 6 that the population can be quite heterogeneous.  Since the FACS 381 
gates that we used were quite stringent, we skewed our cells towards the equivalent of the mouse T1 382 
population which may be less diverse and less representative of that portion of cells that are 383 
precursors to naïve cells. In this context it is interesting that a prior comparison of human T1 and T2 384 
cells also showed a difference in IGHJ6 usage (11). Without the immature B cell repertoire to give 385 
this context this could be interpreted as IGHJ6 being removed gradually from the repertoire.  386 
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However, in the light of the fact that our transitional cells have higher IGHJ6 than either immature 387 
cells or naïve cells then this is unlikely.  In reality, this CD10 very high population has a very 388 
distinctive repertoire in many other respects also, and therefore likely has a completely different 389 
function.  Whether this would be the regulatory B cell subset or not would require further 390 
investigation in the future.  391 
In summary, we have shown that there are strong selective influences over the B cell repertoire in early 392 
B cell development, and we can identify genes and characteristics that are likely to be detrimental by 393 
the fact that they disappear from the repertoire in development.  The selection effects are mainly on the 394 
heavy chain rather than the light chain genes. This is surprising considering the role that receptor editing 395 
is thought to play in central tolerance, and may mean that either the heavy chain plays a dominant role 396 
in receptor specificity, or that switching between kappa and lambda is the chief mode of receptor 397 
editing. An unexpected finding was that the transitional subset of cells with the highest level of CD10 398 
expression may not really be a transitional stage between immature and naïve B cells, and further work 399 
will be required to determine whether these represent the regulatory B cells. 400 
 401 
Acknowledgements. 402 
The authors are extremely grateful to all the staff and patients at the orthopaedic unit of Guy’s 403 
Hospital and to the funders: This work was supported by a joint programme from the MRC and 404 
BBSRC (MR/L01257X/1) and also by funds from the Dunhill Medical Trust (R279/0213) and a 405 
CASE award from the BBSRC in conjunction with MedImmune (BB/L015854/1). 406 
  407 
P ovis
ional
17 
 
References 408 
 409 
1. Gathings WE, Lawton AR, Cooper MD. Immunofluorescent studies of the development of 410 
pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol. 411 
1977;7(11):804-10. 412 
2. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and 413 
characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med. 414 
1991;173(5):1213-25. 415 
3. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-416 
621. 417 
4. Schroeder HW, Jr. The evolution and development of the antibody repertoire. Front Immunol. 418 
2015;6:33. 419 
5. Santos P, Arumemi F, Park KS, Borghesi L, Milcarek C. Transcriptional and epigenetic 420 
regulation of B cell development. Immunol Res. 2011;50(2-3):105-12. 421 
6. Halverson R, Torres RM, Pelanda R. Receptor editing is the main mechanism of B cell 422 
tolerance toward membrane antigens. Nat Immunol. 2004;5(6):645-50. 423 
7. Keenan RA, De Riva A, Corleis B, Hepburn L, Licence S, Winkler TH, et al. Censoring of 424 
autoreactive B cell development by the pre-B cell receptor. Science. 2008;321(5889):696-9. 425 
8. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant 426 
autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374-7. 427 
9. Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, et al. Novel human 428 
transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982-429 
93. 430 
10. Boyd SD, Liu Y, Wang C, Martin V, Dunn-Walters DK. Human lymphocyte repertoires in 431 
ageing. Curr Opin Immunol. 2013;25(4):511-5. 432 
11. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and 433 
characterization of circulating human transitional B cells. Blood. 2005;105(11):4390-8. 434 
12. Simon Q, Pers JO, Cornec D, Le Pottier L, Mageed RA, Hillion S. In-depth characterization 435 
of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy 436 
Clin Immunol. 2016;137(5):1577-84 e10. 437 
13. Petro JB, Gerstein RM, Lowe J, Carter RS, Shinners N, Khan WN. Transitional type 1 and 2 438 
B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem. 439 
2002;277(50):48009-19. 440 
14. Chung JB, Sater RA, Fields ML, Erikson J, Monroe JG. CD23 defines two distinct subsets of 441 
immature B cells which differ in their responses to T cell help signals. Int Immunol. 2002;14(2):157-442 
66. 443 
15. von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune 444 
disease. Nat Immunol. 2010;11(1):14-20. 445 
16. Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in 446 
murine splenic B cell development. J Immunol. 2002;168(5):2101-10. 447 
17. Roy V, Chang NH, Cai Y, Bonventi G, Wither J. Aberrant IgM signaling promotes survival 448 
of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand black mice. J 449 
Immunol. 2005;175(11):7363-71. 450 
18. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. 451 
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are 452 
functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129-40. 453 
19. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, et al. A new CD21low B 454 
cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004;113(2):161-71. 455 
20. Bemark M. Translating transitions - how to decipher peripheral human B cell development. J 456 
Biomed Res. 2015;29(4):264-84. 457 
Provis
i al
18 
 
21. Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-458 
throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and 459 
switched memory B-cell populations. Blood. 2010;116(7):1070-8. 460 
22. Wu YC, Kipling D, Dunn-Walters DK. The relationship between CD27 negative and positive 461 
B cell populations in human peripheral blood. Front Immunol. 2011;2:81. 462 
23. Martin V, Bryan Wu YC, Kipling D, Dunn-Walters D. Ageing of the B-cell repertoire. Philos 463 
Trans R Soc Lond B Biol Sci. 2015;370(1676). 464 
24. DeKosky BJ, Lungu OI, Park D, Johnson EL, Charab W, Chrysostomou C, et al. Large-scale 465 
sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. 466 
Proc Natl Acad Sci U S A. 2016;113(19):E2636-45. 467 
25. Martin V, Wu YC, Kipling D, Dunn-Walters DK. Age-related aspects of human IgM(+) B 468 
cell heterogeneity. Ann N Y Acad Sci. 2015;1362:153-63. 469 
26. Larimore K, McCormick MW, Robins HS, Greenberg PD. Shaping of human germline IgH 470 
repertoires revealed by deep sequencing. J Immunol. 2012;189(6):3221-30. 471 
27. Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, et al. 472 
Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol. 473 
2000;1(3):207-13. 474 
28. Townsend C. L., Laffy J. MJ, Wu YC, Silva O'Hare J, Martin V., David K., et al. Significant 475 
differences in physicochemical properties of human immunoglobulin kappa and lambda CDR3 476 
regions. Frontiers Immunology. 2016;Manuscript submitted. 477 
29. Wu YC, Kipling D, Dunn-Walters D. Assessment of B Cell Repertoire in Humans. Methods 478 
in molecular biology (Clifton, NJ). 2015;1343:199-218. 479 
30. Alamyar E, Giudicelli V, Li S, Duroux P, Lefranc MP. IMGT/HIGHV-QUEST: The IMGT® 480 
web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high 481 
throughput and deep sequencing. Immunome research. 2012;8(1):2. 482 
31. Lefranc MP. Antibody Informatics: IMGT, the International ImMunoGeneTics Information 483 
System. Microbiol Spectr. 2014;2(2). 484 
32. Osorio D, Rondon-Villarreal P, Torres R. Peptides: Calculate Indices and Theoretical 485 
Properties of Protein Sequences. R package version 1.1.1. 2015. 486 
33. Team RC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R 487 
Foundation for Statistical Computing; 2015. 488 
34. Dunn-Walters D. Dunn-Walters' Lab. http://wwwbcellorguk. 489 
35. Soetaert K. plot3D : Tools for plotting 3-D and 2-D data. R package version 10-2. 2014. 490 
36. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. 491 
Journal of Molecular Biology. 1982;157(1):105-32. 492 
37. Boman HG. Antibacterial peptides: basic facts and emerging concepts. Journal of Internal 493 
Medicine. 2003;254(3):197-215. 494 
38. Rice P, Longden I, Bleasby A. EMBOSS: The European molecular biology open software 495 
suite. Trends in Genetics. 2000;16(6):276-7. 496 
39. Ikai A. Thermostability and aliphatic index of globular proteins. Journal of Biochemistry. 497 
1980;88(6):1895-8. 498 
40. Kidera A, Konishi Y, Oka M, Ooi T, Scheraga HA. Statistical analysis of the physical 499 
properties of the 20 naturally occurring amino acids. Journal of Protein Chemistry. 1985;4(1):23-55. 500 
41. Douglas Bates MM, Ben Bolker, Steve Walker. Fitting Linear Mixed-Effects Models using 501 
lme4. Journal of Statistical Software. 2015;67(1):1-48. 502 
42. Qiu P, Simonds EF, Bendall SC, Gibbs KD, Jr., Bruggner RV, Linderman MD, et al. 503 
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol. 504 
2011;29(10):886-91. 505 
43. Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol 506 
Immunol. 1996;210:167-79. 507 
44. Tussiwand R, Bosco N, Ceredig R, Rolink AG. Tolerance checkpoints in B-cell development: 508 
Johnny B good. Eur J Immunol. 2009;39(9):2317-24. 509 
45. Rosner K, Winter DB, Tarone RE, Skovgaard GL, Bohr VA, Gearhart PJ. Third 510 
complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, 511 
P, and N components than non-mutated genes. Immunology. 2001;103(2):179-87. 512 
Pr v s
ion l
19 
 
46. Dorner T, Foster SJ, Farner NL, Lipsky PE. Immunoglobulin kappa chain receptor editing in 513 
systemic lupus erythematosus. J Clin Invest. 1998;102(4):688-94. 514 
47. Woodward EJ, Thomas JW. Multiple germline kappa light chains generate anti-insulin B cells 515 
in nonobese diabetic mice. J Immunol. 2005;175(2):1073-9. 516 
48. Hehle V, Fraser LD, Tahir R, Kipling D, Wu YC, Lutalo PM, et al. Immunoglobulin kappa 517 
variable region gene selection during early human B cell development in health and systemic lupus 518 
erythematosus. Mol Immunol. 2015;65(2):215-23. 519 
49. Abe D, Nakaseko C, Takeuchi M, Tanaka H, Ohwada C, Sakaida E, et al. Restrictive usage of 520 
monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood. 521 
2008;112(3):836-9. 522 
50. Prak EL, Trounstine M, Huszar D, Weigert M. Light chain editing in kappa-deficient animals: 523 
a potential mechanism of B cell tolerance. J Exp Med. 1994;180(5):1805-15. 524 
51. Brezinschek HP, Foster SJ, Dorner T, Brezinschek RI, Lipsky PE. Pairing of variable heavy 525 
and variable kappa chains in individual naive and memory B cells. J Immunol. 1998;160(10):4762-7. 526 
52. Jayaram N, Bhowmick P, Martin AC. Germline VH/VL pairing in antibodies. Protein Eng 527 
Des Sel. 2012;25(10):523-9. 528 
53. Widhopf GF, 2nd, Goldberg CJ, Toy TL, Rassenti LZ, Wierda WG, Byrd JC, et al. 529 
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic 530 
leukemia B cells is predicated on the heavy chain CDR3. Blood. 2008;111(6):3137-44. 531 
54. Agrawal S, Smith SA, Tangye SG, Sewell WA. Transitional B cell subsets in human bone 532 
marrow. Clin Exp Immunol. 2013;174(1):53-9. 533 
55. Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 534 
2015;27(10):479-86. 535 
56. Vossenkamper A, Blair PA, Safinia N, Fraser LD, Das L, Sanders TJ, et al. A role for gut-536 
associated lymphoid tissue in shaping the human B cell repertoire. J Exp Med. 2013;210(9):1665-74. 537 
 538 
Figure Legends 539 
Figure 1. Isolation of B cells early in development. a) B cell development pathway with phenotype 540 
used to distinguish each cell type. Starting from a CD19+ population: B) Example showing the 541 
sorting strategy used to isolate preB (red:IgK-IgL-CD38+IgM+) and immature (orange: IgK+ or 542 
IgL+CD27-IgM+IgD-CD10+) B cells from bone marrow mononuclear cells (BMMCs). C) Sorting 543 
strategy used to isolate transitional (green: IgD+CD27-CD10+) and naïve (blue: IgD+CD27-CD10-) 544 
cells from matched peripheral blood mononuclear cells (PBMC)s. Dotted lines on the plots represent 545 
the gates based on FMO controls and the solid lined boxes represent the gating used to collect the 546 
different subsets.   547 
Figure 2. Heavy chain VDJ gene family usage distinguishes cell types a) Mean frequency 548 
histograms of individual V, D and J family usage for the heavy chain gene families of PreB (red), 549 
immature (yellow), transitional (green) and naïve (blue) cells (*  p<0.05 by 2 way ANOVA with 550 
multiple analysis correction. Error bars are SEM). b) VDJ family combination usage in the different 551 
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cell types. The size of a bubble represents the mean frequency of that VDJ combination. c) 552 
Transitional and Naïve cells show difference in VDJ family usage by principle component analysis 553 
(PCA) (left) compared to a randomised data set (right).  554 
Figure 3: Light chain gene usage and CDR3 properties cannot distinguish between cell types 555 
 a-b) V and J family usage for kappa (a) and lambda (b) light chain gene families between immature 556 
(yellow), transitional (green) and naïve cell types (*  p<0.05 by 2 way ANOVA with multiple analysis 557 
correction. Error bars are SEM).  c-d) light chain VJ usage for kappa (c) and lambda (d) light chains 558 
in immature (yellow), transitional (green) and naïve (blue) B cells. The size of a circle indicates the 559 
relative mean frequency of the VJ combination. e-f) Principle component analysis (PCA) of VJ usage 560 
(e) and kidera factors (f) in three different cell types for kappa (top) and lambda (bottom). 561 
Figure 4: Individual genes can be favoured or disfavoured as B cells mature. a-c) Frequency of 562 
IGHV (a) and IGHD (b) gene usage in heavy chain and IGKV and IGLV usage in light chains (c) of 563 
different cell types are compared (*  p<0.05 by 2 way ANOVA with multiple analysis correction. 564 
Error bars are SEM). d-e) The frequency for each cell type in each individual donor is shown for 565 
genes that are decreased during selection (d) and those that are increased (e). 566 
Figure 5. Heavy chain CDR3 characteristics distinguish between cell types. (a) Distinction 567 
between the different cell types by kidera factors as illustrated by Principle component analysis 568 
(PCA). Distribution of CDRH3 physicochemical properties that have an increased trend from preB 569 
(P) immature (I), transitional (T) to naïve (N) cells (b), and a decrease in naïve cells compared to 570 
preB cells (c) . (* p<0.05 ANOVA).  (d) The heavy chain CDR3 length in all cells types in young and 571 
old donors.(young donors: 18 to 50; old donors: over 65). (* p<0.05 ANOVA). Values on the y axis of 572 
b) to d) are as per the individual graph titles. 573 
Figure 6: Transitional cells have a unique heavy chain immunoglobulin repertoire.  (a, c) 574 
Minkowski distance clustering analysis of heavy chain VDJ family usage (a) and CDRH3 kidera 575 
factors for preB (P) immature (I), transitional (T) and naïve (N) cells in each donor (c).  (b) The 576 
frequency of gene use (%) for different cell types in each individual donor for genes that have a 577 
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distinctive distribution in transitional cells. (d) CDRH3 physicochemical properties in different cell 578 
types for properties that have a distinctive distributions in transitional cells. (* p<0.05 ANOVA). 579 
Values on the y axis of are as per the individual graph titles. (e) High dimensional clustering of 580 
CD24hiCD38hi transitional B cells indicates heterogeneity within the transitional population with 581 
respect to IgM expression, illustrated as a SPADE plot. Populations numbered 1 to 13 have been 582 
grouped according to expression of IgM, IgD, CD21, CD23 as shown in supplementary figure 1. 583 
Figure S1. High High dimensional clustering of CD24hiCD38hi transitional B cells indicates 584 
heterogeneity within the transitional population with respect to IgD, CD21, CD23 expression, 585 
illustrated as a SPADE plot. Populations numbered 1 to 13 have been grouped according to 586 
expression of IgM, IgD, CD21, CD23, see figure 6e for a tabulated summary. 587 
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